38 results about "Urinary output" patented technology

Systems, devices and methods for sensing physiologic data and draining and analyzing bodily fluids are described which are capable of sensing physiologic data based on sensors incorporated into a catheter adapted to reside in any of a urinary tract, gastrointestinal tract, rectal location, pre-peritoneal, pleural space or other body cavity. The devices aid emptying of the bladder, measure urine output and various urine parameters such as oxygen tension, urine conductance and urine specific gravity, monitor renal function, analyze urine parameters, including urine content, including the presence of infection, and track and/or control fluid administration.

A system and method for monitoring and analyzing patient urinary output and a plurality of additional patient physiological parameters. The system comprises a plurality of patient connections and monitoring apparatus for monitoring a plurality of patient physiological parameters. The system further comprises a processor programmed to apply at least one analysis criterion to at least a signal indicative of patient urinary output. The processor further applies additionally more complex analysis criterion to a combination of patient urinary output data and at least one additional patient physiological parameter to provide an automated diagnosis of patient condition.

The invention discloses a new traditional Chinese medicine composition for treating liver ascites symptoms and a preparation method thereof. The traditional Chinese medicine composition is mainly prepared from the following medicine components: cassia twig, tuckahoe, rhizoma alismatis, Plantain seed, fiveleaf akebia, Lobelia, mulberry bark, climbing fern spore, broom cypress fruit, lysimachia, talcum, notopterygium root, ledebouriella root, acanthopanax bark, orientvine, cinnamon, clove, pangolin, dried orange peer, immature bitter orange, nut grass, rhubarb, hemlock parsley, magnolia bark, Chinese yam, white atractylodes rhizome, semen raphani, japanese sweetflag, bush-cherry seed, angelica glabra, Evodia rutaecarpa, galangal, allium macrostemon, Semen Euryales, pyrrosia lingua, ricepaperplant and oriental wormwood. The traditional Chinese medicine composition can be prepared into any commonly-used oral preparation by using the conventional traditional Chinese medicine preparation method. The invention can obviously improve the symptoms of abdominal distention, ascites, difficulty in walking, and probable obvious diaphragm elevation with expiratory dyspnea and exomphalocele before the ocurrence of ascites. Some patients possibly have the symptoms of hydrothorax, increased portal venous pressure, increased hydrostatic pressure abdominal visceral vessel beds, hypoalbuminemia diseases, excessive lymphogenesis, secondary hyperaldosteronism, reduction of renal blood flow, sodium output and urinary output and the like. The traditional Chinese medicine composition has exact and obvious clinical curative effect and high efficiency. By basically combining edible and pharmaceutical products specified in the national pharmacopoeia, the traditional Chinese medicine composition has the advantages of low cost, no toxic or side effects and the like.

It is an object of the present invention to provide a combination of a functional assessment of renal function together with biomarker results in order to improve assessment of patient at risk of or having, an acute kidney injury. A loop diuretic such as furosemide inhibits luminal active chloride transport throughout the thick ascending limb of Henle, thereby preventing sodium reabsorption and resulting in natriuresis and increased urine flow. Loop diuretic-induced increases in urine output might be a method to assess the integrity of the renal tubular function in the setting of early AKI, and so a kidney's response, or lack thereof, to a diuretic challenge as a clinical assessment of tubular function can identify patients with severe tubular injury before it is clinically apparent (e.g. a rise in creatinine).

A device (100) for determining an appropriately sized medical undergarment for a wearer includes a housing (101) and a wheel (102). A first body mass index factor alignment indicator (108) can be aligned with a first body mass index factor, such as weight of a wearer, thereby revealing color coded symbols (109) aligned with a plurality of second body mass factor alignment indicators (110). A user selects the appropriate size by determining which color is aligned with a second body mass factor alignment indicator of the wearer. An optional second side (205) of the device (100) can be used to determine an appropriate type of medical undergarment based upon urinary output, wearer mobility, or combinations thereof.

Provided herein are compositions (e.g., pharmaceutical compositions, nutraceutical compositions, foods, beverages, cosmetic compositions, diet supplements) comprising deuterated caffeine. The provided compositions may be useful for treating and/or preventing various diseases and conditions, such as obesity, causing weight loss, increasing metabolic rate, reducing appetite, increasing energy expenditure, increasing urine output, increasing sodium excretion, reducing edema, a pain disorder, apnea, hypotension, an encephalopathy, a neurological or psychiatric disorder, and an inflammatory disorder.

A fluid therapy method for an ADHF patient includes setting a urine output rate desired threshold, setting one or more desired negative net gain rates, and optionally setting a total fluid loss goal. The urine output of the patient is monitored and fluid is automatically administered to the patient at increasing rates to equal to or approximately match the patient's increasing urine output rates until the patient's urine output rate reaches the set urine output rate desired threshold. Thereafter, fluid is administered to the patient at rates to achieve the set desired negative net gain rate until the fluid loss goal is reached. Thereafter, until the end of therapy, fluid is administered to the patient at rates equal to or approximately equal to the monitored urine output rates.

A device for measuring a rate of production of urine in a patient comprising a catheter; a pressure transducer; and a means for measuring the amount of urine produced. Urine flow from the bladder is prevented until a predetermined pressure is reached in the bladder. Urine flow is then allowed; the bladder pressure and the volume of urine exiting the bladder are measured. When the bladder pressure reaches a second, lower predetermined pressure, urine flow is again prevented. From the measured pressure during urine flow and from the volume of urine exiting the bladder, the intra-abdominal pressure and the urine production rate can be determined.

The invention discloses a postoperative patient condition early-warning and monitoring method and system. The method comprises the following steps: S1, acquiring seven physiological parameters of a postoperative patient, wherein the seven physiological parameters comprise pulse, systolic arterial pressure, respiratory rates, body temperatures, consciousness, oxygen saturation and urine volumes; S2, analyzing scores corresponding to ranges of every physiological parameters; S3, adding the scores corresponding to the physiological parameters of the seven physiological parameters so as to obtaina total score value; and S4, judging whether the total score value meets an early-warning triggering value of a corresponding monitoring grade or not, if the total score value meets the early-warningtriggering value, triggering and outputting a corresponding monitoring grade of the postoperative patient, and recommending corresponding nursing and interference measure contents. By adopting the method and system, after the score value of the physiological parameters of the postoperative patient meets a triggering standard, corresponding monitoring grades are displayed, and corresponding nursingand interference measure contents are recommended, so that the monitoring grade of the postoperative patient can be intelligently confirmed, and the postoperative patient can be well monitored.

The invention relates to a new application of traditional Chinese indian lettuce in the pharmaceutical field, in particular to the application of drugs for curing or preventing diabetes. Experiments prove that rats suffering from diabetes due to streptozotocin significantly decrease urinary output, put on weight gradually and significantly decrease blood sugar level after being fed with the aqueous extract of traditional Chinese indian lettuce. Experiments also prove that no evident toxic side effect produces after rats are fed with the traditional Chinese indian lettuce by 200 times more thanan adult equivalent dose by the maximum gavage amount to the rat (0.4 ml/10g).

Provided herein are compositions (e.g., pharmaceutical compositions, nutraceutical compositions, foods, beverages, cosmetic compositions, diet supplements) comprising deuterated caffeine. The provided compositions may be useful for treating and/or preventing various diseases and conditions, such as obesity, causing weight loss, increasing metabolic rate, reducing appetite, increasing energy expenditure, increasing urine output, increasing sodium excretion, reducing edema, a pain disorder, apnea, hypotension, an encephalopathy, a neurological or psychiatric disorder, and an inflammatory disorder.

The embodiment of the invention provides a death prediction method and system for a sepsis-related acute kidney injury patient, equipment and a medium, and belongs to the technical field of medical care information. The method specifically comprises the steps of training an XGBOOST algorithm through a sample data set, and establishing a prediction model; collecting the urine volume, the maximum value of urea nitrogen, the noradrenaline injection rate, the maximum value of anion gap, the maximum value of creatinine, the maximum value of red blood cell distribution width, the minimum value of international standardization ratio, the maximum value of heart rate, the maximum value of body temperature, the minimum value of oxygen uptake fraction, the stroke state, the minimum value of creatinine, the minimum Glasgow coma scale and a diabetes state of a target person; and inputting the key information data set into a prediction model to obtain a prediction result. According to the scheme, the machine learning algorithm is used for learning, the prediction model is established, then the collected key information data set is input into the prediction model, the prediction result is obtained, and the prediction efficiency and accuracy are improved.

The invention relates to the technical field of medical apparatus and instruments, and discloses a special urinal for women, which comprises a urine receiver for receiving urine when women urinate, the urine receiver comprises a urine receiver handle and an arc urine receiving port, and through the arc urine receiving port, the urinal better fits the human body structure and prevents the urine from scattering to other places, the urine receiver far away from one side of the arc urine receiving opening is connected with a pot body for containing urine through a catheter and a pot body joint; the kettle body comprises a kettle body handle and scales; when a patient needs to urinate, the family member of the patient attaches the urine collector to the urination opening of a woman, and then urine enters the pot body through the urine collector and the catheter. According to the invention, the pot body does not need to be cleaned after urination is completed, the pot body can store and take the urine with a certain period of time according to the requirements of a doctor, and the pot body with the urine does not need to be held to directly receive the urine.

Provided herein are compositions (e.g., pharmaceutical compositions, nutraceutical compositions, foods, beverages, cosmetic compositions, nutritional supplements) comprising d9-caffeine. The provided compositions may be useful for treating and/or preventing various diseases and conditions, such as obesity, causing weight loss, increasing metabolic rate, reducing appetite, increasing energy expenditure, decreasing daytime sleepiness, increasing urine output, increasing sodium excretion, reducing edema, a pain disorder, apnea, hypotension, an encephalopathy, a neurological or psychiatric disorder, and an inflammatory disorder.

The invention provides a urethral catheterization metering device. A urine inlet is formed in a catheter metering device and communicates with a distribution chamber through a urine channel; a stop valve is arranged on the urine channel; a distribution chamber inlet and a distribution chamber outlet are formed in the distribution chamber; the distribution chamber inlet is connected with the urinechannel; a metering branch outlet and a urethral catheterization outlet are formed in the distribution chamber outlet; the metering branch outlet communicates with a metering pipeline; the urethral catheterization outlet is connected with a urine outlet pipe; and a liquid drop sensor is arranged on the metering pipeline. The urethral catheterization metering device can effectively meter the urinevolume for reference of medical staff.